Trades on 1 secondary market
Blackthorn Therapeutics
BlackThorn Therapeutics was a clinical-stage biopharmaceutical company founded in 2015 and headquartered in South San Francisco, focused on discovering and developing targeted therapeutics for brain diseases and central nervous system (CNS) disorders such as major depressive disorder and schizophren
Blackthorn Therapeutics is an API provider whose private shares are listed on 1 secondary market: Forge Global.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.